Q4 EPS SEK 3.7 vs ARCe/Cons 3.9. Reported ROE 12.9%Revenues 3% below (mostly trading line), costs in line.. While FY26 cost outlook of SEK 33.4bn +- 0.25bn looks in line/slightly above consSEK 11.0 total DPS (8.5 ordinary, 2.5 XO) better than expected, but buybacks lower..Feels a bit on the weak side overall, share likely to underperform today
